Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublication section updated: added language that publications are provided voluntarily by the person entering information, and the revision label updated to v3.3.2 (replacing the previous phrasing about the study results). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedNotice about lapse in government funding and operating status has been removed; the page no longer provides guidance to check current status on cc.nih.gov or opm.gov.SummaryDifference0.2%

- Check42 days agoChange DetectedTwo screenshots show no substantive changes to the Study Details page; core data remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference0.5%

- Check70 days agoChange Detected- Removed multiple MedlinePlus topics: Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, and Substandard Drugs. - Added a new Revision tag: v3.1.0. Overall, core topic coverage is reduced with a version update.SummaryDifference0.1%

- Check85 days agoChange DetectedVersion bumped to v3.0.2 with a new Informed Consent Form and time-stamped updates; older status/dates and navigation anchor removed.SummaryDifference0.2%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.